We will be conducting a workshop on NGS data analysis and visualization at the Plant and Animal Genome Conference XX in San Diego, January 17, 2012.
We will present an overview of CLC Genomics Workbench, and cover the features of de novo assembly, RNA-Seq, and our resequencing tool using Genomics Gateway in more detail. Genomics Gateway is our new framework for visualizing, combining and analyzing whole genome data.
Our invited speakers - Prof. Juan F. Medrano, Animal Genomics Laboratory, UC Davis and Prof. Claude dePamphilis, Biology Department, Penn State University - are recognized experts within the field of genomics, and will provide their inputs on how they use our tools in their research.
Please join us for interactive presentations from 1:30 to 3:40 pm on January 17 in the Golden West room at the Town and Country Convention Center in San Diego.
In November month’s newsletter we launched a survey where all respondents would enter a draw for an iPad. Yesterday we found the winner and it’s Michael Lauck from David O’Connors lab at the University of Wisconsin-Madison - congratulations!
Here’s a couple of insights from the survey:
- Academic 70.4%, Biotech 7.8%, Pharma 0.9%, Governmental 8.3%, Medical 6.2% and Other 6.4%
- 58% of all the respondents work with NGS analysis an a regular basis
- 18% have one in-house NGS instrument, whereas 29% have between 2-5 instruments. 5% have more than 5 instruments and the rest didn’t have any!
Thanks to everyone who participated!
In July we launched an initiative to support all the researchers investing in benchtop sequencers, like Ion Torrent from Life Technologies, GS Junior from Roche 454, or MiSeq from Illumina. Basically we offer one 6-months license of our premier desktop software package, CLC Genomics Workbench, to researchers and organizations who have bought one of these instruments.
The initiative has gotten a lot more traction than we originally anticipated, which we’re really happy about. Also, we think this is a good indication that the next generation sequencing technology is being democratized, in the sense these machines are being purchased by a lot of organizations who haven’t operated next generation sequencers before.
If you’re interested in learning more and maybe even enter our quarterly competition to win a permanent license, please check out benchtopseq.com
All over the world, we experience tremendous growth in the use of our platform for DNA sequence analysis - especially for high-throughput sequencing data. As a result of this, all our divisions are fast growing and we have an ongoing search for talented people to join us here in our ambitious and fast-growing company! Just this past month, we have increased the number of employees by almost 10% - and we still have many open positions both in Europe, America, and Asia.
Most of our divisions are currently looking to recruit - including Software Development, Sales, and our world famous Support - and we’re looking to hire people in different parts of the world.
If you’re curios to learn more about what it would be like to join our innovative team and make a difference, we encourage you to have a look at the “careers” section on our website - and if your ambitions and skills match any of our job postings, we hope to hear from you soon:
http://clcbio.com/careers
Wouldn’t it be cool if someone put in the effort to write a huge knowledge bank on all kinds of aspects that relates to Next Generation Sequencing? Well, it turns out that someone already did - and it’s free!
This goldmine of sequencing insights has been created by the team of experts at BlueSEQ – maybe you have heard of them and their sequencing exchange already? Anyway, their knowledge bank gives you a detailed comparison of the different sequencing platforms, including the pros and cons of each of them – check it out here
Furthermore you can get unbiased recommendations of which platforms are ideal for which types of applications, like they suggest using 454 for de novo projects of prokaryote genomes, or either Illumina or LifeTech’s SOLiD for transcriptome sequencing - and the list goes on and on.
A lot of this information can of course be found around the internet on vendor websites and forums like SeqAnswers. But the nice thing about this knowledge bank is that you don’t have to trawl through endless pages to find the exact bit of information you need. It’s all there and curated by sequencong pros who don’t have a bias towards any of the platforms.
This impressive resource, including their glossary, can be extremely helpful to scientists who’re new to sequencing or researchers who don’t spend their whole working life doing sequencing, but maybe rather run a couple of projects a year, and then spend the majority of their time analyzing the sequencing data.
So what’s missing? As both platforms mature, I look forward to reading more about how BlueSEQ’s experts see Ion Torrent and PacBio fits in to the comparison table of all the major sequencing platforms and what applications are ideal to run on which platforms - perhaps also taking economics into question!?
